Allarity Therapeutics, Inc. Common Stock (ALLR) is a publicly traded Healthcare sector company. As of May 21, 2026, ALLR trades at $1.49 with a market cap of $22.11M and a P/E ratio of -2.04. ALLR moved -2.35% today. Year to date, ALLR is +33.04%; over the trailing twelve months it is +35.45%. Its 52-week range spans $0.61 to $2.35. Analyst consensus is buy with an average price target of $9.75. Rallies surfaces ALLR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Allarity Therapeutics, Inc. Common Stock (ALLR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ALLR moved -2.35% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.49 |
| Market Cap | $22.11M |
| P/E Ratio | -2.04 |
| EPS | $-0.72 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.35 |
| 52-Week Low | $0.61 |
| Volume | 249 |
| Avg Volume | 0 |
| Revenue (TTM) | $345.00K |
| Net Income | $-11.25M |
| Gross Margin | 0.00% |
1 analysts cover ALLR: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.75.